DVM PHARMACEUTICALS, INC. – Trademark Portfolio
Entity Type: 03
DVM PHARMACEUTICALS, INC. holds 58 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 50 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 5 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include DVM, RELIEF, SYNOVI G3, and CHLORHEXIDERM. The owner is based in MIAMI, FL.
4400 BISCAYNE BOULEVARD
MIAMI, FL 33137
Showing of trademarks Trademarks
Trademark Classifications
DVM PHARMACEUTICALS, INC.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does DVM PHARMACEUTICALS, INC. have?
DVM PHARMACEUTICALS, INC. has 58 U.S. trademarks filed with the USPTO. Of these, 4 registered, 17 abandoned, 37 cancelled.
What trademark classes does DVM PHARMACEUTICALS, INC. file in?
DVM PHARMACEUTICALS, INC. files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 3 (Cosmetics & Cleaning), Class 25 (Clothing), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are DVM PHARMACEUTICALS, INC.'s most well-known trademarks?
DVM PHARMACEUTICALS, INC.'s registered trademark portfolio includes well-known marks such as DVM, RELIEF, SYNOVI G3, and CHLORHEXIDERM. These are among 4 currently registered trademarks in the portfolio.
What is DVM PHARMACEUTICALS, INC.'s trademark registration success rate?
DVM PHARMACEUTICALS, INC. has a 7% trademark registration rate, with 4 out of 58 resolved applications resulting in successful registration. Currently, 0 applications are pending review.